MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Beta-blockers"

  • 2024 International Congress

    Sympathetic Nervous System Overactivity in the Pre-Motor Stage of Parkinson’s Disease: Therapeutic Implications

    M. Tagliati, M. Gregorio, H. Maghzi, G. Obialisi, E. Hogg, C. Malatt, E. Tan, M. Kelly, H. Pomeroy, R. Artal, M. Shehata, B. Renner, Z. Fan, P. Sati, G. Pagano (Los Angeles, USA)

    Objective: To investigate sympathetic nervous system (SNS) activity in idiopathic REM behavior disorder (iRBD) subjects at risk for Parkinson's disease (PD), and the effect of…
  • 2022 International Congress

    Adrenergic blockers and statins are associated with later age of onset in Parkinson’s disease

    C. Malatt, I. Khatiwala, M. Rangwala, A. Maleki, E. Hogg, E. Tan, M. Tagliati (Los Angeles, USA)

    Objective: To evaluate the association of anti-hypertensives, non-steroidal anti-inflammatories (NSAIDs), statins, diabetes medications, smoking and family history of idiopathic Parkinson’s disease (iPD) with age of…
  • MDS Virtual Congress 2021

    Beta-antagonists and risk of Parkinson’s disease: Meta-analysis of real-world evidence studies

    A. Singh, S. Hussain, B. Antony (Hobart, Australia)

    Objective: We performed a systematic review and meta-analysis of real-world evidence (RWE) studies evaluating the association between use of β-antagonist and the risk of PD.…
  • MDS Virtual Congress 2020

    Beta-adrenoreceptor medications and risk of Parkinson’s disease

    X. Li, L. Wang, Y. Zhang (Guangzhou, China)

    Objective: To review and analyze the associations between β-adrenoreceptor medications and risk of Parkinson's disease. Background: Distinctive Lewy body mainly composed of α-synuclein is an…
  • 2019 International Congress

    Development Of Anti-Parkinsonism Poly Herbal Sustained Release Formulation Composed Of Potential Traditional Plant Extracts

    S. Jain, A. Jain, S. Bhargav (Sagar, India)

    Objective: Parkinsonism is one of the commonest neurodegenerative diseases, which is characterized by a selective and progressive degeneration of dopaminergic neurons, causing a series of…
  • 2019 International Congress

    Acute hypertensive crisis with myoclonic movements induced by withdrawal of intrathecal combined clonidine and morphine administration

    A. Saryyeva, J. Krauss, L. Cassini Ascencao (Hannover, Germany)

    Objective: Clonidine is a centrally acting alpha(2)-agonist antihypertensive drug used for opioid/alcohol withdrawal and for intrathecal administration in the treatment of chronic neuropathic pain. Cases…
  • 2019 International Congress

    Adrenergic Receptor Modulation of Non-Motor Symptoms in Parkinson’s Disease

    M. Rangwala, E. Hogg, E. Tan, H. Lu, A. Garland Becerra, M. Tagliati (Los Angeles, CA, USA)

    Objective: To analyze the correlation between the use of beta-blockers (BB) and the prevalence of non-motor symptoms in patients with Parkinson’s disease (PD). Background: In…
  • 2016 International Congress

    Insulin dependent diabetes and hand tremor

    S. Khachaturyan, G. Avagyan, K. Harutyunyan, A. Voskanyan, I. Gabrielyan, H. Amirjanyan, H. Manvelyan (Echmiadzin, Armenia)

    Objective: Tremor is the most common type of involuntary movement. Clinically tremor can be classified into physiological, essential, dystonic, Parkinsonian and psychogenic. Risk for hand…

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley